Four keys to building your company's synthetic biology strategy Big incumbent companies can't afford to fall behind in a new tech-and-science arms race. Fortune · Mar 3, 2023
A.I.'s uniqueness shakes up the risk-benefit calculus for business leaders Business leaders may have to change their decision-making processes to adapt to the distinctive properties of artificial intelligence. Fortune · Dec 2, 2022